ConductScience.org, home

Paper27273113

Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.

Balasubramanian A and 7 others. Osteoporos Int, 2016. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Papers, record 27273113. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27273113

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.
PubMed
Journal
Osteoporos Int
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
3.63
iCite
Revised in PubMed
2018-12-02
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Balasubramanian AA
2Wade SWS W
3Adler RAR A
4Lin CJFC J F
5Maricic MM
6O'Malley CDC D
7Saag KK
8Curtis JRJ R

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Fractures, BoneMajor topic
GlucocorticoidsMajor topic
Adult
Female
Humans
Incidence
Male
Middle Aged
Prednisone
Retrospective Studies
Risk Factors

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119750051Interpreting estimates of treatment effects: implications for managed care.P T2008https://conductscience.org/library/papers/19750051PubMed
220406615
High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial.
Clin Exp Rheumatol2010https://conductscience.org/library/papers/20406615PubMed
311145036
Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register.
Arthritis Rheum2000https://conductscience.org/library/papers/11145036PubMed
417414948Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.Curr Opin Rheumatol2007https://conductscience.org/library/papers/17414948PubMed
510841167Use of oral corticosteroids and risk of fractures.J Bone Miner Res2000https://conductscience.org/library/papers/10841167PubMed
61619449Identification of fractures from computerized Medicare files.J Clin Epidemiol1992https://conductscience.org/library/papers/1619449PubMed
722539481Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.Rheumatology (Oxford)2012https://conductscience.org/library/papers/22539481PubMed
811093437A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.J Rheumatol2000https://conductscience.org/library/papers/11093437PubMed
911777359
Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.
Ann Intern Med2002https://conductscience.org/library/papers/11777359PubMed
1019106733Identification and validation of vertebral compression fractures using administrative claims data.Med Care2009https://conductscience.org/library/papers/19106733PubMed
1111254818Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.Thorax2001https://conductscience.org/library/papers/11254818PubMed
1214613287Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.Arthritis Rheum2003https://conductscience.org/library/papers/14613287PubMed
1315672413The population risk of fractures attributable to oral corticosteroids.Pharmacoepidemiol Drug Saf2005https://conductscience.org/library/papers/15672413PubMed
149263140Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.J Rheumatol1997https://conductscience.org/library/papers/9263140PubMed
1511136882Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.Rheumatology (Oxford)2000https://conductscience.org/library/papers/11136882PubMed
1624764264Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis.Rheumatology (Oxford)2014https://conductscience.org/library/papers/24764264PubMed
177984782Glucocorticoid-induced osteoporosis.Rheum Dis Clin North Am1994https://conductscience.org/library/papers/7984782PubMed
189517579Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease.Am J Respir Crit Care Med1998https://conductscience.org/library/papers/9517579PubMed
1912378366The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.Osteoporos Int2002https://conductscience.org/library/papers/12378366PubMed
20224739172012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.Arthritis Care Res (Hoboken)2012https://conductscience.org/library/papers/22473917PubMed

See all 41 referencesDownload CSV of references

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
42301302Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.Osteoporos Int2026https://conductscience.org/library/papers/42301302PubMed
42097691
Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis.
RMD Open2026https://conductscience.org/library/papers/42097691PubMed
41419188High disease activity is associated with incident osteoporotic fractures among veterans with rheumatoid arthritis.Joint Bone Spine2026https://conductscience.org/library/papers/41419188PubMed
40846759Mind the bone: a protocol for osteoporosis prophylaxis in patients with thyroid eye disease on intravenous methylprednisolone.Eye (Lond)2025https://conductscience.org/library/papers/40846759PubMed
40721250Epidemiology and factors associated with osteoporosis, falls and fractures in patients with chronic inflammatory rheumatic disease: a scoping review.BMJ Open2025https://conductscience.org/library/papers/40721250PubMed
40665152Association between ramelteon use and risk of fragility fractures: A retrospective cohort study.Arch Osteoporos2025https://conductscience.org/library/papers/40665152PubMed
39992470Ukrainian guideline for the prevention and treatment of glucocorticoid-induced osteoporosis.Arch Osteoporos2025https://conductscience.org/library/papers/39992470PubMed
39432088Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.Osteoporos Int2025https://conductscience.org/library/papers/39432088PubMed
39411912Circulating Baseline CXCR3+Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis.ACR Open Rheumatol2025https://conductscience.org/library/papers/39411912PubMed
39155862Potential of resveratrol in the treatment of systemic lupus erythematosus (Review).Mol Med Rep2024https://conductscience.org/library/papers/39155862PubMed
38516640Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users.SAGE Open Med2024https://conductscience.org/library/papers/38516640PubMed
38396490Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis.Diagnostics (Basel)2024https://conductscience.org/library/papers/38396490PubMed
38267664
Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int2024https://conductscience.org/library/papers/38267664PubMed
37550762
Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years.
BMC Rheumatol2023https://conductscience.org/library/papers/37550762PubMed
37253115Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?Endocr Rev2023https://conductscience.org/library/papers/37253115PubMed
36856881Bad to the bones: prescribing of drugs for the prevention and treatment of osteoporosis in patients on chronic glucocorticoids.Arch Osteoporos2023https://conductscience.org/library/papers/36856881PubMed
36627860Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica.Womens Health (Lond)2023https://conductscience.org/library/papers/36627860PubMed
35855327COVID-19 Pandemic and Osteoporosis in Elderly Patients.Aging Dis2022https://conductscience.org/library/papers/35855327PubMed
35189819Activation of dopamine receptor D1 promotes osteogenic differentiation and reduces glucocorticoid-induced bone loss by upregulating the ERK1/2 signaling pathway.Mol Med2022https://conductscience.org/library/papers/35189819PubMed
35059661Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study.JAAD Int2022https://conductscience.org/library/papers/35059661PubMed

See all 51 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27273113

GET https://conductscience.org/api/papers/v1/27273113/references?page=2